Abstract
Genetic testing and counseling for epilepsy are now being incorporated into everyday practice in many parts of the industrialized world. This advance has mainly been driven by rapid discoveries in the etiology of monogenic epilepsies, paired with technological developments in next-generation sequencing (NSG), allowing the parallel and economical testing of multiple target genes.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call